Menu
ETF
Annual · values202420232022202120202019
Operating Cash Flow-4.18 M USD-9.43 M USD-747297 USD-5.79 M USD-1.65 M USD-232000 USD
Depreciation & Amortization
Stock-Based Compensation
Capital Expenditures
Cash Flow from Investing-2.10 M USD
Cash Flow from Financing3.40 M USD10.40 M USD2.10 M USD
Dividends Paid
Stock Buybacks0 USD-64.28 M USD0 USD
Free Cash Flow-4.18 M USD-9.43 M USD-993000 USD-1.05 M USD-64000 USD0 USD

Ocean Biomedical Inc. is a life sciences company that focuses on developing and commercializing innovative therapeutics. The company's primary function is to bridge the gap between cutting-edge research and the practical treatment of diseases, particularly those with significant unmet medical needs. Ocean Biomedical collaborates with leading research universities and medical institutions to harness their groundbreaking discoveries for clinical applications. By doing so, they target multiple sectors within the biomedical field, including oncology, infectious diseases, and other critical therapeutic areas. The company plays a significant role in the healthcare market by potentially transforming promising scientific breakthroughs into viable medical treatments, thereby facilitating advancements in patient care and health outcomes globally. Ocean Biomedical Inc.'s work contributes to the dynamic and rapidly evolving landscape of medical science, continually pushing the boundaries of what is possible in the fight against complex diseases.